ECM
ASTH icon

Everence Capital Management’s Astrana Health ASTH Stock Holding History

Everence Capital Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,690
Closed -$272K – 1055
2024
Q3 		$272K Buy
+4,690
New +$230K 0.02% 633
2023
Q4 		– Sell
-6,870
Closed -$212 – 814
2023
Q3 		$212 Hold
6,870
– – 0.02% 654
2023
Q2 		$217K Hold
6,870
– – 0.02% 628
2023
Q1 		$251 Hold
6,870
– – 0.02% 603
2022
Q4 		$203 Hold
6,870
– – 0.02% 690
2022
Q3 		$268K Hold
6,870
– – 0.02% 549
2022
Q2 		$265K Hold
6,870
– – 0.02% 559
2022
Q1 		$333K Hold
6,870
– – 0.03% 531
2021
Q4 		$505K Buy
+6,870
New +$564K 0.04% 410

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Everence Capital Management's ASTH Position: Q4 2024 in Review

Everence Capital Management sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 4,690 shares — an estimated $272K sold.

Everence Capital Management first reported a position in ASTH in Q4 2021 and held it in 9 quarters. The position peaked at $505K in Q4 2021. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Everence Capital Management reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Everence Capital Management sold 4,690 Astrana Health shares in Q4 2024, an estimated $272K.
  • Everence Capital Management first reported a position in Astrana Health in Q4 2021 and held it in 9 quarters.
  • Everence Capital Management's Astrana Health position peaked at $505K in Q4 2021.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Everence Capital Management's 13F filing for Q4 2024, filed 3 Jan 2025.